← Open Payments lookup

KAEGAN CULLISON: Open Payments

NPI 1912744004 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$857 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $380 · 2025 $857

Food & beverage: $857
CompanyPaymentsAmount
Madrigal Pharmaceuticals11$465
Intercept Pharmaceuticals, Inc.5$165
Takeda Pharmaceuticals U.S.A., Inc.2$58
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$52
Veloxis Pharmaceuticals, Inc.2$50
Vanda Pharmaceuticals Inc.1$24
Eton Pharmaceuticals, Inc.1$24
Gilead Sciences, Inc.1$18

Products named: REZDIFFRA, OCALIVA, LIVTENCITY, XIFAXAN, ENVARSUS, FANAPT, GALZIN.

Industry payments across OK — which companies pay providers there.